Filter Results :

Your search for Lymphoma returned 100 reports

Sort by


Global Diffuse Large B Cell Lymphoma Drug Market, Dosage, Price & Clinical Pipeline Outlook 2024

01 Mar 2018  |  Published by:  KuicK Research
Global Diffuse Large B Cell Lymphoma Drug Market, Dosage, Price & Clinical Pipeline Outlook 2024” Report Highlights:• Price & Dosage Analysis of Commercially Available Drugs• Patent, Price & Dosage Analysis of  Recently Approved Drugs• Market Analysis of Diffuse Large B Cell Lymphom...

$ 2,400.00

Read More

Hodgkin Lymphoma (B-Cell Hodgkin Lymphoma) - Pipeline Review, H1 2018

20 Feb 2018  |  Published by:  Global Markets Direct
SummaryGlobal Markets Direct's latest Pharmaceutical and Healthcare disease pipeline guide Hodgkin Lymphoma (B-Cell Hodgkin Lymphoma) - Pipeline Review, H1 2018, provides an overview of the Hodgkin Lymphoma (B-Cell Hodgkin Lymphoma) (Oncology) pipeline landscape.Hodgkin lymphoma is a cancer that sta...

$ 2,000.00

Read More

Leukemia & Lymphoma Society Inc - Strategic SWOT Analysis Review

31 Jan 2018  |  Published by:  GlobalData
Leukemia & Lymphoma Society Inc - Strategic SWOT Analysis Review provides a comprehensive insight into the company's history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company's key employees, key competitors and major...

$ 125.00

Read More

Global Large Cell Lymphoma Market Research Report 2018

10 Jan 2018  |  Published by:  9Dimen Research
Large Cell Lymphoma Report by Material, Application, and Geography - Global Forecast to 2022 is a professional and in-depth research report on the world's major regional market conditions, focusing on the main regions (North America, Europe and Asia-Pacific) and the main countries (United States, Ge...

$ 2,850.00

Read More

Follicular Lymphoma Treatment Market: Global Market Estimation, Dynamics, Regional Share, Trends, Competitor Analysis 2012 to 2016 and Forecast 2017 to 2023

10 Jan 2018  |  Published by:  Precision Business Insights
Global Follicular Lymphoma Treatment Market: By Treatment Type (Chemotherapy, Targeted Therapy, Radiotherapy, Monoclonal Antibodies, Stem Cell Transplantation), By Route of Administration (Oral, Parenteral), By End-User (Hospitals, Oncology Centers, Academic Research Institutes) and Geography – Mark...

$ 4,400.00

Read More

Global CAR T Cell Therapy Market (By Targeted antigen - HER1, HER2, CD19, CD20, CD22, CD30, CD33, GD2, MESO and EGFRvIII, By Treatment - Non-Hodgkin Lymphoma (NHL), Chronic Lymphocytic Leukemia (CLL), Acute Lymphoblastic Leukemia (ALL), Multiple Myeloma, Acute Myeloid Leukemia (AML), Breast Cancer, Pancreatic Cancer, Neuroblastoma (NB), Colon Cancer And Hepatocellular Carcinoma (HCC)) - Global Industry Analysis, Size, Share, Growth, Trends and Forecast, 2017 - 2025

01 Jan 2018  |  Published by:  Sheer Analytics & Insights
The report covers the analysis and forecast of the CAR T cell therapy market on global as well as regional level. The study provides historic data of 2016 along with the forecast for the period between 2017 and 2025 based on revenue (US$ Million).The study provides a detailed view of the CAR T cell ...

$ 4,795.00

Read More

Lymphoblastic Lymphoma Global Clinical Trials Review, H2, 2017

30 Nov 2017  |  Published by:  GlobalData
Summary“Lymphoblastic Lymphoma Global Clinical Trials Review, H2, 2017" provides an overview of Lymphoblastic Lymphoma clinical trials scenario. This report provides top line data relating to the clinical trials on Lymphoblastic Lymphoma. Report includes an overview of trial numbers and their averag...

$ 2,500.00

Read More

The Leukemia & Lymphoma Society Inc - Pharmaceuticals & Healthcare - Deals and Alliances Profile

28 Nov 2017  |  Published by:  GlobalData
SummaryThe Leukemia & Lymphoma Society Inc (LLS) is a health organization that offers funding research, finding cures and access to treatments for blood cancer patients. The organization's services include patient support, health education, policy advocacy, funds raising and medical research funding...

$ 250.00

Read More

Non-Hodgkin Lymphoma - Pipeline Review, H2 2017

28 Nov 2017  |  Published by:  Global Markets Direct
SummaryGlobal Markets Direct's latest Pharmaceutical and Healthcare disease pipeline guide Non-Hodgkin Lymphoma - Pipeline Review, H2 2017, provides an overview of the Non-Hodgkin Lymphoma (Oncology) pipeline landscape.Non-Hodgkin lymphoma (also known as non-Hodgkin’s lymphoma, NHL, or sometimes jus...

$ 2,500.00

Read More

Tissue Diagnostics Market by Product (Consumables, Instruments), Technology (Immunohistochemistry, in Situ Hybridization, Digital Pathology & Workflow), Disease (Breast Cancer, Gastric Cancer, Lymphoma), End User (Hospital, CRO) - Global Forecast to 2022

09 Nov 2017  |  Published by:  MarketsandMarkets
Global tissue diagnostics market projected to grow at a CAGR of 6.9% during the forecast periodThe tissue diagnostics market is expected to reach USD 5.14 billion by 2022 from USD 3.68 billion in 2017, at a CAGR of 6.9%. Factors driving the growth of this market include the rising incidence of cance...

$ 5,650.00

Read More

Peripheral T-Cell Lymphomas (PTCL) - Pipeline Insights, 2017

01 Nov 2017  |  Published by:  DelveInsight
DelveInsight’s, “Peripheral T-Cell Lymphoma (PTCL)-Pipeline Insights, 2017”, report provides comprehensive insights about pipeline drugs across this indication. A key objective of the report is to establish the understanding for all the pipeline drugs that fall under Peripheral T-Cell Lymphoma (PTCL...

$ 1,250.00

Read More

B-Cell Non-Hodgkin Lymphoma - Pipeline Insight, 2017

01 Nov 2017  |  Published by:  DelveInsight
DelveInsight’s, “B-Cell Non-Hodgkin Lymphoma -Pipeline Insights, 2017”, report provides comprehensive insights of the ongoing therapeutic research and development across B-Cell Non-Hodgkin Lymphoma . The report provides a complete understanding of the pipeline activities covering all clinical, pre-c...

$ 1,500.00

Read More

B-Cell Lymphomas - Pipeline Insight, 2017

01 Nov 2017  |  Published by:  DelveInsight
DelveInsight’s, “B-Cell Lymphomas -Pipeline Insights, 2017”, report provides comprehensive insights of the ongoing therapeutic research and development across B-Cell Lymphomas . The report provides a complete understanding of the pipeline activities covering all clinical, pre-clinical and discovery ...

$ 2,000.00

Read More

Anaplastic Large Cell Lymphoma (ALCL) - Pipeline Insight, 2017

01 Nov 2017  |  Published by:  DelveInsight
DelveInsight’s, “Anaplastic Large Cell Lymphoma (ALCL) -Pipeline Insights, 2017”, report provides comprehensive insights of the ongoing therapeutic research and development across Anaplastic Large Cell Lymphoma (ALCL) . The report provides a complete understanding of the pipeline activities covering...

$ 1,250.00

Read More

Indolent Lymphoma - Epidemiology Insights to 2025

01 Nov 2017  |  Published by:  DelveInsight
DelveInsight’s “Indolent Lymphoma -Epidemiology Forecast, 2025” provides an overview of the epidemiology trends of Indolent Lymphoma in seven major markets (US, France, Germany, Italy, Spain, UK and Japan). It includes 10 years epidemiology historical and forecasted data of Indolent Lymphoma. The Re...

$ 2,950.00

Read More
Total 100 records.